Immunome's market cap is currently $840.82M. The company's EPS TTM is $-8.117; its P/E ratio is ―; Immunome is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.67. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 14.02M	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -8.91M	$ -631.00K	$ -755.00K	$ -755.00K	$ -615.00K
Operating Income	$ -109.53M	$ -36.90M	$ -25.20M	$ -12.26M	$ -10.35M
EBITDA	$ -28.27M	$ -36.27M	$ -23.95M	$ -17.04M	$ -9.72M
Net Income	$ -106.81M	$ -37.51M	$ -24.47M	$ -17.12M	$ -10.55M
Balance Sheet
Cash & Short-Term Investments	$ 138.14M	$ 20.32M	$ 49.23M	$ 39.77M	$ 2.54M
Total Assets	$ 148.54M	$ 24.05M	$ 57.92M	$ 44.52M	$ 5.06M
Total Debt	$ 1.65M	$ 293.00K	$ 317.00K	$ 613.00K	$ 564.00K
Net Debt	$ -97.03M	$ -20.03M	$ -48.91M	$ -39.15M	$ -1.98M
Total Liabilities	$ 28.66M	$ 7.39M	$ 9.74M	$ 3.18M	$ 40.69M
Stockholders' Equity	$ 119.88M	$ 16.65M	$ 48.19M	$ 41.34M	$ -35.63M
Cash Flow
Free Cash Flow	$ -8.40M	$ -28.94M	$ -18.30M	$ -12.72M	$ -9.83M
Operating Cash Flow	$ -7.57M	$ -28.69M	$ -18.23M	$ -12.13M	$ -9.60M
Investing Cash Flow	$ -30.48M	$ -248.00K	$ -79.00K	$ -586.00K	$ -233.00K
Financing Cash Flow	$ 116.41M	$ 32.00K	$ 27.77M	$ 49.94M	$ 10.77M

Currency in USD

Immunome Earnings and Revenue History

Income Statement >

Immunome Debt to Assets

Balance Sheet >

Immunome Cash Flow

Cash Flow >

Immunome Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing